Logo image of OPTN

OPTINOSE INC (OPTN) Stock Fundamental Analysis

NASDAQ:OPTN - Nasdaq - US68404V2097 - Common Stock - Currency: USD

9.6  -0.11 (-1.13%)

After market: 9.65 +0.05 (+0.52%)

Fundamental Rating

2

OPTN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 193 industry peers in the Pharmaceuticals industry. OPTN may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, OPTN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OPTN has reported negative net income.
OPTN had a negative operating cash flow in the past year.
OPTN had negative earnings in each of the past 5 years.
OPTN had a negative operating cash flow in each of the past 5 years.
OPTN Yearly Net Income VS EBIT VS OCF VS FCFOPTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M -100M

1.2 Ratios

OPTN has a Return On Assets of -27.65%. This is comparable to the rest of the industry: OPTN outperforms 55.84% of its industry peers.
Industry RankSector Rank
ROA -27.65%
ROE N/A
ROIC N/A
ROA(3y)-33.85%
ROA(5y)-40.79%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OPTN Yearly ROA, ROE, ROICOPTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

OPTN has a Gross Margin of 90.91%. This is amongst the best in the industry. OPTN outperforms 94.92% of its industry peers.
In the last couple of years the Gross Margin of OPTN has remained more or less at the same level.
OPTN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 90.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.13%
GM growth 5Y1.39%
OPTN Yearly Profit, Operating, Gross MarginsOPTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K

More info and screens

1

2. Health

2.1 Basic Checks

OPTN does not have a ROIC to compare to the WACC, probably because it is not profitable.
OPTN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, OPTN has less shares outstanding
The debt/assets ratio for OPTN has been reduced compared to a year ago.
OPTN Yearly Shares OutstandingOPTN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
OPTN Yearly Total Debt VS Total AssetsOPTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -7.97, we must say that OPTN is in the distress zone and has some risk of bankruptcy.
OPTN has a Altman-Z score of -7.97. This is in the lower half of the industry: OPTN underperforms 68.02% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.97
ROIC/WACCN/A
WACC14.65%
OPTN Yearly LT Debt VS Equity VS FCFOPTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.77 indicates that OPTN may have some problems paying its short term obligations.
OPTN has a worse Current ratio (0.77) than 87.82% of its industry peers.
A Quick Ratio of 0.70 indicates that OPTN may have some problems paying its short term obligations.
With a Quick ratio value of 0.70, OPTN is not doing good in the industry: 85.79% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.7
OPTN Yearly Current Assets VS Current LiabilitesOPTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

6

3. Growth

3.1 Past

OPTN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.00%.
OPTN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.20%.
OPTN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.70% yearly.
EPS 1Y (TTM)-40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.67%
Revenue 1Y (TTM)10.2%
Revenue growth 3Y1.57%
Revenue growth 5Y17.7%
Sales Q2Q%24.4%

3.2 Future

The Earnings Per Share is expected to grow by 16.78% on average over the next years. This is quite good.
Based on estimates for the next years, OPTN will show a very strong growth in Revenue. The Revenue will grow by 23.27% on average per year.
EPS Next Y1.39%
EPS Next 2Y16.33%
EPS Next 3Y23.14%
EPS Next 5Y16.78%
Revenue Next Year27.03%
Revenue Next 2Y20.08%
Revenue Next 3Y20.15%
Revenue Next 5Y23.27%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OPTN Yearly Revenue VS EstimatesOPTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
OPTN Yearly EPS VS EstimatesOPTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -10 -20 -30 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OPTN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OPTN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPTN Price Earnings VS Forward Price EarningsOPTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPTN Per share dataOPTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

OPTN's earnings are expected to grow with 23.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.33%
EPS Next 3Y23.14%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OPTN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPTINOSE INC

NASDAQ:OPTN (5/20/2025, 8:25:10 PM)

After market: 9.65 +0.05 (+0.52%)

9.6

-0.11 (-1.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners77.15%
Inst Owner Change0%
Ins Owners5.94%
Ins Owner Change-8.65%
Market Cap97.25M
Analysts78
Price Target9.18 (-4.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)95.84%
Min EPS beat(2)95.84%
Max EPS beat(2)95.84%
EPS beat(4)3
Avg EPS beat(4)54.7%
Min EPS beat(4)-9.44%
Max EPS beat(4)95.84%
EPS beat(8)6
Avg EPS beat(8)42.57%
EPS beat(12)9
Avg EPS beat(12)28.61%
EPS beat(16)12
Avg EPS beat(16)23.38%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)-0.81%
Revenue beat(4)1
Avg Revenue beat(4)1.18%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)8.75%
Revenue beat(8)5
Avg Revenue beat(8)4.58%
Revenue beat(12)5
Avg Revenue beat(12)0.35%
Revenue beat(16)8
Avg Revenue beat(16)0.3%
PT rev (1m)-50%
PT rev (3m)-62.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.73
EYN/A
EPS(NY)-1.69
Fwd EYN/A
FCF(TTM)-4.42
FCFYN/A
OCF(TTM)-4.41
OCFYN/A
SpS9.19
BVpS-3.98
TBVpS-3.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.65%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 90.91%
FCFM N/A
ROA(3y)-33.85%
ROA(5y)-40.79%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.13%
GM growth 5Y1.39%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.44%
Cap/Sales 0.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.7
Altman-Z -7.97
F-Score5
WACC14.65%
ROIC/WACCN/A
Cap/Depr(3y)39.45%
Cap/Depr(5y)36.44%
Cap/Sales(3y)0.21%
Cap/Sales(5y)0.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6.67%
EPS Next Y1.39%
EPS Next 2Y16.33%
EPS Next 3Y23.14%
EPS Next 5Y16.78%
Revenue 1Y (TTM)10.2%
Revenue growth 3Y1.57%
Revenue growth 5Y17.7%
Sales Q2Q%24.4%
Revenue Next Year27.03%
Revenue Next 2Y20.08%
Revenue Next 3Y20.15%
Revenue Next 5Y23.27%
EBIT growth 1Y-7.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.94%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-114.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.61%
OCF growth 3YN/A
OCF growth 5YN/A